The Science of Glivec
Learn more about Glivec cutting edge molecularly-targeted treatment mechanism and its application in CML and GIST treatment regimens.
MOLECULAR TARGETHelping Patients
Find out how Glivec is transforming the management and treatment of certain cancers, including CML and GIST.
HUMAN IMPACTGIPAP
The international patient assistance programme, GIPAP is open in about 80 countries. As of November 30, 2007 the total number of patients reached was 19,378.
GIPAP
Read important Glivec press releases:
Hassan l, et al.
Surgically Managed Gastrointestinal Stromal Tumours (GIST): A Comparative and Prognostic Analysis. Annals of Surgical
Oncology 2008 Jan
U.S. Residents
